FormulationsDownload

Products

Quality Std.

Indication

Regularity Status

Tech Pack

Patent

Human Use

US DMF

EUR EDMF

EU
CEP

JAP DMF

CAN DMF

AUS DMF

KOR DMF

BRA DMF

MEX DMF

Ambrisentan

IHS

Pulmonary hypertension

Apixaban

IHS

Anti-Congulant

Asenapine Maleate

IHS

Schizophrenia

IN/PCT

Bosentan Monohydrate

IHS

Pulmonary hypertension

IN/PCT/US/EP

Cinacalcet HCl

IHS

Hyperparathyroidism

IN/PCT/U

S/EP

Darifenacin HBr

IHS

Overactive Bladder

Desvenlafaxine Succinate

IHS

Depression

Donepezil Base

IHS

Alzheimer's

Donepezil HCl Form I

USP/IP

Alzheimer's

Donepezil HCl Form III

USP/JP/IP

Alzheimer's

Iloperidone

IHS

Schizophrenia

Lurasidone HCL

IHS

Schizophrenia

Memantine HCl

USP

Alzheimer's

Mirabegron

IHS

Overactive Bladder

IN/PCT

Mirtazapine Anhydrous

USP/EP

Depression

Mirtazapine Hemihydrate

USP / EP / IP

Depression

S-Mirtazapine

IHS

Depression

Paliperidone

IHS

Schizophrenia

IN/PCT

Prasugrel Base

IHS

Anti - thrombotic

Prasugrel HCl

IHS

Anti - thrombotic

Quetiapine Hemifumarate

IP/EP

Schizophrenia

Rivaroxaban

IHS

Anti-coagulant

IN/PCT/US/EP

Solifenacin Succinate

IHS

Overactive Bladder

IN/PCT

Teriflunomide

IHS

Multiple sclerosis

Ticagrelor

IHS

Acute coronary syndrome

IN/ PCT/
US/EP

Venlafaxine HCl

USP/EP

Depression

Vilazodone HCl

IHS

Depression

Vildagliptin

IHS

Diabetes

IN/PCT

Ziprasidone HCI

USP/EP

Schizophrenia

Veterinary Use

Morantel Citrate

IHS

Anthelmintic

Morantel Tartrate

USP/EP/BP

Anthelmintic

Oxantel Pamoate

IHS

Anthelmintic

Pyrantel Pamoate/
Embonate

USP/EP/
JP/IP

Anthelmintic

Pyrantel Tartrate

IHS

Anthelmintic

Under Development

Apremilast

Psoriatic Arthritis

Blonanserin (Lonasen)

Anti-Schizophrenia

Dabigatran

Anti - coagulant

Ivabradine

Anti - anginal

Macitentan

Pulmonary hypertension

Riociguat

Pulmonary hypertension

Selexipag

Pulmonary hypertension

Vilazodone HCl

Depression

Vortioxetine HBr

Depression

Under Consideration

Brexpiprazole

Depression/Schizophrenia

Edoxaban

Anti - coagulant

Ivacaftor

Cystic Fibrosis

Lumacaftor

Cystic Fibrosis

Paliperidone Palmitate

Schizophrenia

Suvorexant

Insomnia

Indicates: DMF Filed
Indicates: DMF to be Filed
CEP Granted
CEP Applied
Tech Pack Availble

IHS - In-House Specs
IN - Indian Patent PCT - Patent Co-operation Treaty US - US Patent EP - Europe Patent

DISCLAIMER - Products protected under specific patents are available for R&D / Regulatory use strictly in accordance with the Indian Patent Act (as amended) and not offered for commercial exploitation.

2.	2-Hydroxy-3-methoxy-3, 3-diphenyl propanoic acid	DPA-III	178306- 51-9
3.	(2S)-2-Hydroxy-3-methoxy-3, 3-diphenyl propanoic acid	DPA-IV	178306- 52-0

4.	Ethyl chloro [(4-methoxyphenyl) hydrazono]acetate	EMA	27143- 07-3
5.	3,3-dichloro-1-(4-nitrophenyl) piperidin-2 -one	APB-III	881386- 01-2
6.	1-(4-nitrophenyl)-3- morpholin-4-yl-5, 6- dihydropyridin-2(1H)-one	APB-IV	503615- 03-0
7.	Ethyl 6-(4-nitrophenyl)-1-(4-methoxyphenyl)-7- oxo-4,5,6,7-tetrahydro-1H-pyrazolo [3,4-c]pyridine-3-carboxylicacid ethyl ester	APB-VI	536759- 91-8

9.	11-Chloro-2,3-dihydro-2-methyl-1H-dibenz[2,3:6,7] oxepino[4,5-c] pyrrol-1-one	DOP	1012884- 46-6
10.	Trans-11-Chloro-2,3,3a, 12b-tetrahydro-2- methyl-1H-dibenz [2, 3:6, 7] oxepino [4,5-c]pyrrol-1-one	TOP	129385- 59-7

12.	(R)-(+)-1- (1-Naphthyl) ethylamine HCl	RNA (IV)	82572- 04-1
13.	3-[3- (Trifluoromethyl) phenyl] propanol	TPP-II	78573- 45-2
14.	1-(3-Bromopropyl) -3- ( trifluoromethyl) benzene	TPP-III	129254- 76-8

15.	Ethyl 3-(4- (methylamino)- 3-nitro-N-(pyridin-2-yl) benzamido) propanoate	DEM-I	429659- 01-8
16.	3-[(3-Amino- 4-methyl aminobenzoyl) pyridin- 2-ylamino]propionic acid ethyl ester	DEM-II	212322- 56-0
17.	3-[[[2-[[(4-Cyanophenyl)amino] methyl]-1-methyl-1H- benzimidazol-5-yl] carbonyl]Pyridine-2- 1Hbenzo[ acid ethyl ester	DEM-III	211915- 84-3
18.	Ethyl 3-(2-((4- carbamimidoyl phenylamino) methyl) 1Hbenzo[ d]imidazole- 5-carboxamido) propanoate HCl	DEM-IV	429658- 95-7
19.	Dabigatran etexilate base	DEM-V	211915- 06-9

21.	5,6-Dimethoxy-2-(pyridin-4-yl methylene) -indan-1-one	DOH-IV	4803- 74-1
22.	1-Benzyl piperidine-4-carbaldehyde	NBP	22065- 85-6
23.	1-Benzyl-4-[(5,6-dimethoxy indanon)-2-ylidenyl] methylpiperidine	DON1	120014- 07-5

26.	(1R,2R)-Cyclohexane-1,2-diyldimethanol	HMC	65376- 05-8
27.	3-Piperazin-1-yl-1,2-benzisothiazole	PBT-FB	87691- 87-0
28.	(3aR,4S,7R,7aS) -hexahydro-4,7-methano- 2H-isoindole-1,3-dione	BHC	14805- 29-9

30.	2-(4-Nitrophenyl ethanamine HCl	NPA.HCl	29968- 78-3
31.	R-2-Hydroxy-N -[2-(4- nitrophenyl) ethyl] -2-phenyl acetamide	MBR-I	521 284- 19-5
32.	(R)-2-[2??(4-Nitrophenyl) ethyl]amino] -1-phenylethanol HCl	MBR-II	521 284- 21-9
33.	R-2-[[2-(4-Aminophenyl)ethyl]-amino] -1-phenylethanol HCl	MBR-III	521 284- 22-0

34.	N-Methyl-3-phenyl piperazine	NM3PP	5271- 27-2
35.	1-(3-Hydroxymethyl pyridyl-2)-2-phenyl -4-methylpiperazine	HMPPMP	61337- 89-1

38.	Disodium pamoate	DSP	6640- 22-8
39.	Pamoic acid	PA	130-85-8
40.	1,2-Dimethyl-1,4,5,6- tetrahydropyrimidine	THP	4271- 96-9

41.	Dibenzo-[b,f][1,4]-thiazepine-11(10H)-one	DTO	3159-07-7
42.	N-[Dibenzo-[b,f][1,4]-thiazepaine-11-yl] piperazine di-HCL	DTPD	111974-74-4
43.	1-(2-(2-Hydroxyethoxy)-ethyl)piperazine	HEEP	13349-82-1

45.	4-(4-Aminophenyl)- 3-morpholinone	AMO	438056- 69-0
46.	2-({(5S)-2-Oxo-3-[4-(3-oxomorpholin-4-yl) phenyl]-1, 3-oxazolidin- 5-yl}methyl)- 1H-isoindole-1,3(2H)-dione	RIV-II	446292- 08-6
47.	4-{4-[(5S)-5- (Aminomethyl)-2-oxo-1, 3-oxazolidin-3-yl] phenyll}morpholin- 3-one HCl	RIV-III	898543- 06-1
48.	2-[(S)-2-Oxiranylmethyl]-1H-isoindole-1,3- (2H)-dione	OXI	161596- 47-0

52	1-[2-(Amino)-1-(4-methoxyphenyl ethyl)] cyclohexanol HCl	AMCH	149289- 31-6
53.	1-[2-(Amino)-1-(4-methoxyphenyl ethyl)] cyclohexanol acetate	AMCA	--------------

54.	Ethyl-5-aminobenzofuran- 2-carboxylate	EABC	174775- 48-5
55.	Ethyl 5-piperazin-1-yl-1-benzofuran-2-carboxylate	PBC	163521- 20-8
56.	3-(4-Chlorobutyl)-1H-indole-5- carbonitrile	CIC	143612- 79-7

57.	3-Aminoadamantan-1-ol	HAA	702- 82-9
58.	(2S)-1-(Chloroacetyl) pyrrolidine-2- carbonitrile	CCP-II	207557- 35-5

60.	6-Chloro-2-oxindole	6-CO	56341- 37-8
61.	6-Chloro-5-(chloroacetyl)-1,3-dihydro- 2H-indole-2-one	ZIP I	118307- 04-3
62.	6-Chloro-5-(chloroethyl)-1,3-dihydro- 2H-indole-2-one	ZIP II	118289- 55-7
63.	3-Piperazin-1-yl-1,2- benzisothiazole HCl	PBT	87691- 88-1
64.	Ziprasidone free base	ZPH-I	146939- 27-7

FormulationsDownload

IHS - In-House Specs IN - Indian Patent PCT - Patent Co-operation Treaty US - US Patent EP - Europe Patent

DISCLAIMER - Products protected under specific patents are available for R&D / Regulatory use strictly in accordance with the Indian Patent Act (as amended) and not offered for commercial exploitation.

intermediatesDownload

IHS - In-House Specs
IN - Indian Patent PCT - Patent Co-operation Treaty US - US Patent EP - Europe Patent